author-photo

Bora Lim

Baylor College of Medicine

6

Papers

6

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple negative breast cancer.

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Inflammatory breast cancer: early recognition and diagnosis is critical.

2021 American Journal of Obstetrics and Gynecology
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathological features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma

2021 Human Pathology
Show All
- Source
- Cite
- Save
Citations (0)
PD-L1 in Breast Cancer: The oad to the erfect iomarker is raught with ncertainty.

2021 Journal of the National Cancer Institute
- Bora Lim
Show All
- Source
- Cite
- Save
Citations (2)
The impact of gut microbial composition on response to neoadjuvant chemotherapy (NACT) in early-stage triple negative breast cancer (TNBC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)